Journal articleMol Pharm2022
Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
- Journal
- Mol Pharm
- Published
- 31 May 2022
- Citations
- 12
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 6
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targets, Modulators and Delivery Program P30CA036727↗
- Development and Application of a Porcine Model of Pancreatic Cancer R01CA222907↗
- Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer R01CA259080↗
- Cancer Biology Training Program T32CA009476↗
- Pancreatic Cancer Detection Consortium U01CA210240↗